A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver

Clinical trial NCT02693067 · UNKNOWN

Trial details

NCT number: NCT02693067
Sponsor: Provectus Biopharmaceuticals, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Neuroendocrine Tumors Metastatic to the Liver

Start date: 2016-07-01
Primary completion: 2021-09-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.